CompletedPhase 3NCT00494507
Hyper- and Hypokalemic Periodic Paralysis Study
Studying Genetic periodic paralysis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Rochester
- Principal Investigator
- Robert C. Griggs, M.D.University of Rochester
- Intervention
- Dichlorphenamide (double-blind)(drug)
- Enrollment
- 71 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2007 – 2013
Study locations (12)
- UCLA Neurology, Los Angeles, California, United States
- University of California-San Francisco, San Francisco, California, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Brigham & Women's Hospital, Boston, Massachusetts, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Columbia University Medical Center, New York, New York, United States
- University of Rochester, Rochester, New York, United States
- Ohio State University, Columbus, Ohio, United States
- University of Texas Southwestern-Dallas, Dallas, Texas, United States
- University of Milan, San Donato, Milan, Italy
- Institute of Neurology-Queen's Square, London, United Kingdom
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00494507 on ClinicalTrials.gov